Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial. - Mann,J.F.; Schmieder,R.E.; McQueen,M. (Lancet, 2008)